Search for: "BRISTOL-MYERS SQUIBB" Results 41 - 60 of 870
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
29 Sep 2007, 9:21 pm
The United State Attorney for Massachusetts reports in a press release that "Bristol-Myers Squibb Company (BMS) and its wholly owned subsidiary, Apothecon, Inc., have agreed to pay in excess of $515 million to resolve a broad array of federal and... [read post]
10 Nov 2009, 2:01 am
Regina (Bristol-Myers Squibb Pharmaceuticals Ltd) v National Institute for Health and Clinical Excellence [2009] EWHC 2722 (Admin); [2009] WLR (D) 318 "Art 6 of Council Directive 89/105/EEC relating to the transparency of measures regulating the pricing of medicinal products for human use and their inclusion in the scope of national health insurance systems (OJ L40) ('the [...] [read post]
21 Dec 2016, 2:45 pm by Juliet Preston - MedCity News
PsiOxus Therapeutics has signed a second agreement with Bristol-Myers Squibb (BMS), this time for worldwide rights to its ‘armed’ oncolytic virus NG-348, currently in the preclinical research phase. [read post]
7 Apr 2009, 4:08 am
Andrew Bodnar, a former top executive at Bristol-Myers Squibb Co , faces up to a year in jail after pleading guilty to lying to federal officials about a deal to block a generic version of the company's top-selling medicine.Bodnar, who was a senior vice president of strategy and a member of Bristol's executive committee, was indicted a year ago for misleading statements to the U.S. [read post]
10 Feb 2012, 12:39 pm
., Canada's largest pharmaceutical manufacturer, has paid Bristol-Myers Squibb Co. and Sanofi SA nearly $445 million in damages to end a decade-long patent infringement lawsuit over Apotex' improper sales of its generic version of Plavix. [read post]
5 Aug 2016, 1:09 pm by taotiadmin
In 1993, the California Legislature enacted the Insurance Frauds Prevention Act (“IFPA”) in a unique effort to combat rampant insurance… The post Bristol-Myers Squibb Agrees To Pay $30 million To Settle Whistleblower Case Brought Under The California Insurance Fraud Prevention Act (IFPA) appeared first on TZ Legal - Fraud Fighters. [read post]
12 Jan 2019, 10:12 am by Doyle, Barlow & Mazard PLLC
On January 11, 2019, Congressman Peter Welch and Francis Rooney, members of Congress, wrote a letter to the Federal Trade Commission (“FTC”), urging the Commission to investigate Bristol-Myers Squibb’s (“BMS”) acquisition of Celgene. [read post]
12 Mar 2020, 2:33 pm by Wystan Ackerman
Circuit and Seventh Circuit issued decisions addressing a question that has been hotly debated by class action lawyers on the plaintiffs’ and defense sides: whether the Supreme Court’s decision on personal jurisdiction in Bristol-Myers Squibb Co. v. [read post]
4 Feb 2010, 7:31 am
Jhaveri, a native of India, was a Technical Operations Associate with Bristol-Myers-Squibb for a little over two years until he was fired." [read post]
2 Apr 2021, 9:45 am by anne
How Bristol-Myers Squibb and other Pharma Companies Misrepresent Average Manufacturer Prices This week’s settlement resolves allegations that Bristol-Myers Squibb improperly calculated AMPs for many of its drugs in order to reduce the rebates it owed – and increase the share paid by Medicaid. [read post]
5 Aug 2016, 8:30 am by Kristen Law Sagafi
This month, after nearly a decade of litigation, Bristol-Myers Squibb agreed to pay $30 million to settle an IFPA lawsuit that was filed in 2007 by three former Bristol-Myers employees. [read post]
19 Aug 2006, 4:49 am
A Department of Justice criminal investigation into an agreement between Bristol-Myers Squibb and generic drug-maker Apotex regarding a $40 million payment to the company to keep a generic version of Plavix, one of Bristol-Myers best selling drugs, from the market... [read post]
4 Feb 2010, 7:31 am
Jhaveri, a native of India, was a Technical Operations Associate with Bristol-Myers-Squibb for a little over two years until he was fired. [read post]
3 Apr 2021, 5:00 am by Paul Caron
Almost nine years ago, Bristol Myers Squibb filed paperwork in Ireland to create a new offshore subsidiary. [read post]
7 Aug 2012, 8:10 am by Robert J. Tannous
On August 2, 2012, the Securities and Exchanges Commission ("SEC") charged an executive in the treasury department at Bristol-Myers Squibb with insider trading. [read post]